<DOC>
	<DOCNO>NCT00888381</DOCNO>
	<brief_summary>The purpose study assess efficacy safety CSL 's 2009/2010 formulation Enzira vaccine .</brief_summary>
	<brief_title>A Study Assess Immunogenicity Safety CSL 's 2009 / 2010 Formulation Enzira® Vaccine Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<criteria>Males female age ≥ 18 year time provide informed consent Participants capable understanding purpose risk study able provide write informed consent Willing able adhere protocol requirement Able provide sample approximately 17 mL venous blood two separate occasion without undue distress/discomfort Females child bear potential ( i.e . ovulating , premenopausal , surgically sterile ) must abstinent willing use medically accept contraceptive regimen duration study Known hypersensitivity previous dose influenza vaccine allergy egg , chicken protein , neomycin , polymyxin , component Enzira® vaccine Clinical sign active infection and/or elevate oral temperature ( ≥ 38.0°C ) study entry A clinically significant medical psychiatric condition A confirm suspected immunosuppressive condition History seizures History GuillainBarré Syndrome Vaccination seasonal influenza virus vaccine experimental influenza virus vaccine 6 month precede study entry Currently receive treatment radiotherapy cytotoxic drug , receive treatment within 6 month precede administration Enzira® vaccine Currently receive systemic glucocorticoid therapy ( exclude topical inhale preparation ) receive therapy within 3 month precede study entry Currently receive immunoglobulin and/or blood product receive treatment within 3 month precede administration Enzira® vaccine Currently participate another investigational study recent study participation end 3 month precede administration Enzira® vaccine Currently receive treatment warfarin anticoagulant Evidence history substance alcohol abuse within 12 month study entry Females child bear potential planning become pregnant planning discontinue contraceptive precaution study period Females pregnant lactate Any issue , opinion investigator , would render subject unsuitable study participation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>